Epilepsy Study Consortium Inc
Epilepsy Study Consortium Inc shows strong financial health with growing assets and no liabilities.
EIN: 204950952 · Herndon, VA · NTEE: G54 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.5M |
| Total Expenses | $1.7M |
| Program Spending | 90% |
| Net Assets | $3.5M |
| Transparency Score | 92/100 |
Is Epilepsy Study Consortium Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Epilepsy Study Consortium Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Epilepsy Study Consortium Inc
Epilepsy Study Consortium Inc (EIN: 204950952) is a nonprofit organization based in Herndon, VA, classified under NTEE code G54. The organization reported total revenue of $2.5M and total assets of $3.7M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Epilepsy Study Consortium Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Epilepsy Study Consortium Inc is a mid-size nonprofit that has been operating for 19 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 12.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.4M |
| Total Expenses | $1.7M |
| Surplus / Deficit | +$1.7M |
| Total Assets | $3.5M |
| Net Assets | $3.5M |
| Operating Margin | 49.5% |
| Months of Reserves | 24.4 months |
Financial Health Grade: A
In 2023, Epilepsy Study Consortium Inc reported a surplus of $1.7M with revenue exceeding expenses, holds 24.4 months of operating reserves (strong position).
Financial Trends
Over 13 years of filings (2011–2023), Epilepsy Study Consortium Inc's revenue has grown at a compound annual growth rate (CAGR) of 12.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +58.4% | -11.3% | +93.6% |
| 2022 | +17.9% | +45.9% | +13.4% |
| 2021 | +11.3% | -39.7% | +45.4% |
| 2020 | -18.4% | -24.3% | -33.9% |
| 2019 | -17.6% | -11.1% | -35.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2007 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Epilepsy Study Consortium Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 90%
- fundraising: 0%
According to IRS 990 filings, Epilepsy Study Consortium Inc allocates its expenses as follows: admin: 10%, programs: 90%, fundraising: 0%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $1.7M, with revenue exceeding expenses.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that officers are either unpaid volunteers or compensated through other entities, which is highly favorable for donor perception regarding administrative overhead.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Epilepsy Study Consortium Inc:
- Strong financial health with consistent asset growth, reaching $3,454,178 in 2023.
- No reported liabilities across all 13 IRS 990 filings, indicating excellent financial stability.
- 0% officer compensation reported in all filings, suggesting efficient use of funds for mission-related activities.
- Significant surplus in the latest fiscal year (2023), with revenue of $3,371,798 exceeding expenses of $1,701,465.
- Consistent filing of IRS 990s over 13 periods, demonstrating a commitment to transparency.
Frequently Asked Questions about Epilepsy Study Consortium Inc
Is Epilepsy Study Consortium Inc a legitimate charity?
Epilepsy Study Consortium Inc (EIN: 204950952) is a registered tax-exempt nonprofit based in Virginia. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $2.5M. No red flags identified. 5 strengths noted. Financial health grade: A.
How does Epilepsy Study Consortium Inc spend its money?
Epilepsy Study Consortium Inc directs 90% of its spending to programs and services. This exceeds the 65% industry benchmark.
Are donations to Epilepsy Study Consortium Inc tax-deductible?
Epilepsy Study Consortium Inc is registered as a tax-exempt nonprofit (EIN: 204950952). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How does Epilepsy Study Consortium Inc compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), Epilepsy Study Consortium Inc is above average for NTEE category G54 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Epilepsy Study Consortium Inc located?
Epilepsy Study Consortium Inc is headquartered in Herndon, Virginia and files with the IRS under EIN 204950952. It is classified under NTEE code G54.
How many years of IRS 990 filings does Epilepsy Study Consortium Inc have?
Epilepsy Study Consortium Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.5M in total revenue.
Is Epilepsy Study Consortium Inc a good charity?
Based on the provided financial data, Epilepsy Study Consortium Inc appears to be a very good charity. It demonstrates strong financial health, consistent asset growth, no reported liabilities, and 0% officer compensation, all of which are positive indicators of responsible stewardship.
How has the organization's financial health changed over time?
The organization has shown consistent revenue generation, with some fluctuations, but a clear trend of asset growth from $2,807,974 in 2014 to $3,454,178 in 2023. Notably, the latest fiscal year (2023) shows a significant surplus with revenue of $3,371,798 against expenses of $1,701,465, indicating improved financial performance.
What is the organization's approach to executive compensation?
The organization consistently reports 0% officer compensation across all 13 filings, suggesting that its leadership is either entirely volunteer-based or compensated through external arrangements, which minimizes direct administrative costs from the organization's budget.
Filing History
IRS 990 filing history for Epilepsy Study Consortium Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Epilepsy Study Consortium Inc's revenue has grown by 319.6%, moving from $804K to $3.4M. Total assets increased by 545% over the same period, from $536K to $3.5M. Total functional expenses rose by 131.3%, from $736K to $1.7M. In its most recent filing year (2023), Epilepsy Study Consortium Inc reported a surplus of $1.7M, with revenue exceeding expenses.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.4M | $1.7M | $3.5M | $0 | — | View 990 |
| 2022 | $2.1M | $1.9M | $1.8M | $0 | — | View 990 |
| 2021 | $1.8M | $1.3M | $1.6M | $0 | — | View 990 |
| 2020 | $1.6M | $2.2M | $1.1M | $0 | — | — |
| 2019 | $2.0M | $2.9M | $1.6M | $0 | — | View 990 |
| 2018 | $2.4M | $3.2M | $2.5M | $0 | — | View 990 |
| 2017 | $2.4M | $1.8M | $3.4M | $0 | — | View 990 |
| 2016 | $3.1M | $2.6M | $2.8M | $0 | — | View 990 |
| 2015 | $1.6M | $2.2M | $2.2M | $0 | — | View 990 |
| 2014 | $1.3M | $1.0M | $2.8M | $0 | — | View 990 |
| 2013 | $1.1M | $1.1M | $2.5M | $0 | — | View 990 |
| 2012 | $2.7M | $815K | $2.5M | $0 | — | View 990 |
| 2011 | $804K | $736K | $536K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.4M, expenses of $1.7M, and assets of $3.5M (revenue +58.4% year-over-year).
- 2022: Revenue of $2.1M, expenses of $1.9M, and assets of $1.8M (revenue +17.9% year-over-year).
- 2021: Revenue of $1.8M, expenses of $1.3M, and assets of $1.6M (revenue +11.3% year-over-year).
- 2020: Revenue of $1.6M, expenses of $2.2M, and assets of $1.1M (revenue -18.4% year-over-year).
- 2019: Revenue of $2.0M, expenses of $2.9M, and assets of $1.6M (revenue -17.6% year-over-year).
- 2018: Revenue of $2.4M, expenses of $3.2M, and assets of $2.5M (revenue +2.0% year-over-year).
- 2017: Revenue of $2.4M, expenses of $1.8M, and assets of $3.4M (revenue -24.2% year-over-year).
- 2016: Revenue of $3.1M, expenses of $2.6M, and assets of $2.8M (revenue +93.5% year-over-year).
- 2015: Revenue of $1.6M, expenses of $2.2M, and assets of $2.2M (revenue +21.0% year-over-year).
- 2014: Revenue of $1.3M, expenses of $1.0M, and assets of $2.8M (revenue +22.8% year-over-year).
- 2013: Revenue of $1.1M, expenses of $1.1M, and assets of $2.5M (revenue -60.4% year-over-year).
- 2012: Revenue of $2.7M, expenses of $815K, and assets of $2.5M (revenue +240.9% year-over-year).
- 2011: Revenue of $804K, expenses of $736K, and assets of $536K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Epilepsy Study Consortium Inc:
Data Sources and Methodology
This transparency report for Epilepsy Study Consortium Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.